|Bid||269.75 x 800|
|Ask||271.77 x 1200|
|Day's range||263.79 - 273.13|
|52-week range||240.50 - 340.11|
|Beta (5Y monthly)||0.66|
|PE ratio (TTM)||15.17|
|Earnings date||02 Feb 2024|
|Forward dividend & yield||4.92 (1.83%)|
|Ex-dividend date||05 Dec 2023|
|1y target est||347.81|
U.S. health insurers Cigna and Humana are in talks to merge, a potential deal likely to face aggressive scrutiny from the U.S. Justice Department (DOJ) if antitrust history with similarly sized deals is any indication. The DOJ in 2017 successfully stopped Anthem, now Elevance Health, from buying Cigna for $54 billion, and thwarted Aetna's plan to purchase rival Humana for $34 billion.
Nearly a decade after Cigna and Humana first tried to join forces, the two are at it again.